HR 6867119th CongressIn Committee

NIH Clinical Trial Integrity Act

Standard Summary
Balanced plain-English summary

This bill directs the National Institutes of Health to require clinical-trial sponsors to set and report measurable diversity goals for recruitment and retention by race, ethnicity, age, and sex. It also supports public education, grants, and studies on reducing barriers to participation.

Key Points

  • 1Requires NIH-approved clinical trials to include measurable recruitment and retention goals for underrepresented groups.
  • 2Mandates reporting on participant demographics and retention, with privacy protections.
  • 3Creates remediation plans for trials that miss goals and allows some exceptions or waivers.
  • 4Funds a national awareness campaign and grants to diversify trial participation.
  • 5Directs studies on cost barriers and federal actions affecting trial participation.

Impact Areas

Clinical trial sponsors and researchersNational Institutes of HealthPatients and underrepresented communitiesHealthcare professionalsCommunity-based organizations
Generated by deepseek/deepseek-v4.1-flash-1017Nov 18, 2026